116 related articles for article (PubMed ID: 26453060)
1. Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: a joint mass spectrometry and circular dichroism investigation.
Marzo T; Scaletti F; Michelucci E; Gabbiani C; Pescitelli G; Messori L; Massai L
Biometals; 2015 Dec; 28(6):1079-85. PubMed ID: 26453060
[TBL] [Abstract][Full Text] [Related]
2. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
[TBL] [Abstract][Full Text] [Related]
3. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
Xi Z; Guo W; Tian C; Wang F; Liu Y
Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c).
Gamberi T; Massai L; Magherini F; Landini I; Fiaschi T; Scaletti F; Gabbiani C; Bianchi L; Bini L; Nobili S; Perrone G; Mini E; Messori L; Modesti A
J Proteomics; 2014 May; 103():103-20. PubMed ID: 24705091
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization.
Belviso BD; Galliani A; Lasorsa A; Mirabelli V; Caliandro R; Arnesano F; Natile G
Inorg Chem; 2016 Jul; 55(13):6563-73. PubMed ID: 27305454
[TBL] [Abstract][Full Text] [Related]
6. The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.
Levy AR; Turgeman M; Gevorkyan-Aiapetov L; Ruthstein S
Protein Sci; 2017 Aug; 26(8):1609-1618. PubMed ID: 28543811
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication.
Gamberi T; Magherini F; Fiaschi T; Landini I; Massai L; Valocchia E; Bianchi L; Bini L; Gabbiani C; Nobili S; Mini E; Messori L; Modesti A
Mol Biosyst; 2015 Jun; 11(6):1653-67. PubMed ID: 25906354
[TBL] [Abstract][Full Text] [Related]
9. Conserved residue modulates copper-binding properties through structural dynamics in human copper chaperone Atox1.
Xi Z; Shi C; Tian C; Liu Y
Metallomics; 2013 Nov; 5(11):1566-73. PubMed ID: 24056613
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study.
Cirri D; Marzo T; Tolbatov I; Marrone A; Saladini F; Vicenti I; Dragoni F; Boccuto A; Messori L
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944502
[TBL] [Abstract][Full Text] [Related]
11. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
Brose J; La Fontaine S; Wedd AG; Xiao Z
Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells.
Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P
Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033
[TBL] [Abstract][Full Text] [Related]
13. Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1.
Xi Z; Guo W; Tian C; Wang F; Liu Y
Chem Commun (Camb); 2013 Dec; 49(95):11197-9. PubMed ID: 24150599
[TBL] [Abstract][Full Text] [Related]
14. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
[TBL] [Abstract][Full Text] [Related]
15. The electrochemical profiles of Auranofin and Aubipy
Kupiec M; Ziółkowski R; Massai L; Messori L; Pawlak K
J Inorg Biochem; 2019 Sep; 198():110714. PubMed ID: 31170580
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and copper-mediated nuclease activity of a tetracationic tris(2,2'-bipyridine) ligand.
Arias MS; González-Alvarez M; Fernández MJ; Lorente A; Alzuet G; Borrás J
J Inorg Biochem; 2009 Jul; 103(7):1067-73. PubMed ID: 19515426
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric quantification of the binding ratio of metal-based anticancer complexes with protein thiols.
Han Y; Guo W; Zheng W; Luo Q; Wu K; Zhao Y; Wang F
Rapid Commun Mass Spectrom; 2019 May; 33(10):951-958. PubMed ID: 30812058
[TBL] [Abstract][Full Text] [Related]
18. Binding of Copper and Cisplatin to Atox1 Is Mediated by Glutathione through the Formation of Metal-Sulfur Clusters.
Dolgova NV; Yu C; Cvitkovic JP; Hodak M; Nienaber KH; Summers KL; Cotelesage JJH; Bernholc J; Kaminski GA; Pickering IJ; George GN; Dmitriev OY
Biochemistry; 2017 Jun; 56(24):3129-3141. PubMed ID: 28549213
[TBL] [Abstract][Full Text] [Related]
19. ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs.
Barresi V; Spampinato G; Musso N; Trovato Salinaro A; Rizzarelli E; Condorelli DF
J Inorg Biochem; 2016 Mar; 156():145-52. PubMed ID: 26784148
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of platinum and ruthenium bipyridyl complexes on porcine pancreatic phospholipase A2.
Kamčeva T; Flemmig J; Damnjanović B; Arnhold J; Mijatović A; Petković M
Metallomics; 2011 Oct; 3(10):1056-63. PubMed ID: 21909579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
